Efficacy of agomelatine versus venlafaxine on subjective sleep of patients with major depressive disorder

被引：0
|
作者：
Guilleminault, C [1 ]
机构：
[1] Sleep Disorder Clin, Stanford, CA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S419 / S420
页数：2
相关论文
共 50 条
  • [41] A comparative prospective study of agomelatine versus escitalopram in treatment of severe major depressive disorder
    Petrescu, B.
    Vasile, D.
    Vasiliu, O.
    Mangalagiu, A. G.
    Tudor, C.
    Ungureanu, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S439 - S439
  • [42] ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDER IN SWEDEN
    Clapham, E.
    Berg, J.
    Ekman, M.
    Jonsson, L.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A176 - A176
  • [43] Efficacy and safety of agomelatine in patients with major depressive disorder compared to escitalopram: a randomized, double-blind study
    Quera-Salva, M. -A.
    Hajak, G.
    Keufer-Le Gall, S.
    Nutt, D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 82 - 82
  • [44] Mirtazapine improves tolerability of venlafaxine in hospitalized patients with major depressive disorder
    Smith, DM
    Chan, YC
    Votolato, NA
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 241S - 241S
  • [45] Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine
    Lin, Ching-Hua
    Lin, Keng-Shin
    Lin, Chang-Yi
    Chen, Ming-Chao
    Lane, Hsien-Yuan
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (01) : 54 - 59
  • [46] ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDER IN AUSTRALIA
    O'Leary, B. A.
    Hamann, G. B.
    Adena, M. A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A293 - A294
  • [47] Agomelatine: a guide to its use in major depressive disorder
    [J]. Drugs & Therapy Perspectives, 2010, 26 (2) : 6 - 9
  • [48] THE COST EFFECTIVENESS OF AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Ignatyeva, V
    Avxentyeva, M.
    Frolov, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A411 - A411
  • [49] Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
    Soini, Erkki
    Hallinen, Taru
    Brignone, Melanie
    Campbell, Rosanne
    Diamand, Francoise
    Cure, Sandrine
    Aalto-Setala, Maria
    Danchenko, Natalya
    Koponen, Hannu
    Kolasa, Katarzyna
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (03) : 293 - 302
  • [50] Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder
    Ozdemir, Pinar Guzel
    Boysan, Murat
    Smolensky, Michael H.
    Selvi, Yavuz
    Aydin, Adem
    Yilmaz, Ekrem
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (05) : E645 - E654
12345